Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

SELL
$12.71 - $21.17 $144,080 - $239,983
-11,336 Reduced 35.44%
20,648 $406,000
Q4 2022

Feb 10, 2023

BUY
$11.23 - $19.44 $80,272 - $138,957
7,148 Added 28.78%
31,984 $434,000
Q3 2022

Nov 10, 2022

BUY
$12.2 - $18.71 $108,567 - $166,500
8,899 Added 55.84%
24,836 $434,000
Q2 2022

Aug 05, 2022

BUY
$12.05 - $22.74 $66,985 - $126,411
5,559 Added 53.57%
15,937 $210,000
Q1 2022

May 12, 2022

SELL
$18.32 - $23.03 $68,278 - $85,832
-3,727 Reduced 26.42%
10,378 $235,000
Q4 2021

Feb 10, 2022

BUY
$18.75 - $24.8 $39,093 - $51,708
2,085 Added 17.35%
14,105 $313,000
Q3 2021

Nov 12, 2021

BUY
$19.65 - $31.89 $236,192 - $383,317
12,020 New
12,020 $257,000

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $482M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.